Cancer Crosslinks
  • 2025
  • ABOUT
  • GALLERY
    • 2024
    • 2023 >
      • 2023 Presentations
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
  • Organizers
  • 2025 Presentations

CANCER CROSSLINKS 2023

The 15th Cancer Crosslinks presented on

Thursday, January 26, 2023

New dimensions to the hallmarks of cancer: How is the last decade of discoveries advancing our understanding of cancer biology and transforming precision medicine?

This event included a daytime educational program followed by a
special 15th Cancer Crosslinks afternoon networking session.  
​
Cancer Crosslinks 2023 included 
distinguished international experts who addressed recent progress in the understanding of tumor evolution and emerging diagnostic and treatment options for solid and hematological cancers. An overview of the program is available on this page. 

Event 2023 - International Speakers

Douglas Hanahan, Distinguished Scholar, Ludwig Institute for Cancer Research (Zurich/New York), Professor of Molecular Oncology, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Switzerland (digital talk)

Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute; Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK (Presented during Cancer Crosslinks 2022)

Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (digital talk)

Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany

Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany

Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm Sweden

Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Germany

Event 2023 - Topics

The Hallmarks of Cancer: New Dimensions - Integrating Pre-Clinical and Clinical Cancer Trials of Mechanism-Targeted Therapies (digital talk)
Douglas Hanahan, Distinguished Scholar, Ludwig Institute for Cancer Research (Zurich/New York), Professor of Molecular Oncology, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Switzerland (digital talk)

The natural history of non-small cell lung cancer evolution in TARCERTx
​
Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute; Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK 

Epigenetic (Combination) Therapy – exploiting complex biology to offer novel treatment options for patients with GI cancers
Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (digital talk)

The metabolic regulation of cancer progression
Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany

​Cellular Therapy for solid and hematological tumors: novel targets and technologies
Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany

Data-driven hallmarks of acute myeloid leukemia: biological, prognostic & therapeutic implications
Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm Sweden

AI biomarkers in cancer: recent progress and the way to clinical implementation
Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Germany

Event 2023 - Moderators from Norway

Moderators:
Katarina Puco, Senior Consultant Oncologist, Oslo University Hospital, Institute of Cancer Research and Lovisenberg Diaconal Hospital, Oslo

Eli Sihn Samdal Steinskog, Consultant Oncologist, Department of Oncology, Haukeland University Hospital, Bergen, Norway

Anna Pasetto, Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo; Director of the Center for Advanced Cell Therapy (ACT), Cancer Clinic, Oslo University Hospital

May-Britt Tessem, Associate Professor/Research Scientist, Department of Circulation and Medical Imaging, Faculty of Medicine and Health Services, Norwegian University of Science and Technology (NTNU)

Event 2023 - Travel Voucher
A limited number of travel vouchers are available for clinicians and healthcare personnel based in Norway (domestic travel, first come, first served).  To inquire, please contact 
​
Charlotte Homme, Head of Membership & Events, [email protected]

Event 2023 - Reference Materials 
The Invitation & Program may be downloaded HERE. 

Organizer
Sponsors 2023
Picture
Picture
Picture
To learn more about previous Cancer Crosslinks events, visit the ​GALLERY.

This meeting series is organized by Oslo Cancer Cluster.  Cancer Crosslinks 2023 partners are Bristol Myers Squibb & Eli Lilly.


  • 2025
  • ABOUT
  • GALLERY
    • 2024
    • 2023 >
      • 2023 Presentations
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
  • Organizers
  • 2025 Presentations